Atlas Trials

Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies

Clinical trial NCT03987685 · COMPLETED

Trial details

NCT number
NCT03987685
Sponsor
Athenex, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2018-07-19
Primary completion
2021-01-09
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.